Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models. - Rao NR; Santiago-Marrero I; DeGulis O; Nomura T; Goyal K; Lee S; Hark TJ; Dynes JC; Dexter EX; Dulewicz M; Ge J; Upadhyay A; et al. (Science translational medicine, 2026)